Covid-19 and the growing disadvantage in US life expectancy
- PMID: 34162590
- DOI: 10.1136/bmj.n1530
Covid-19 and the growing disadvantage in US life expectancy
Conflict of interest statement
Competing interests: I have read and understood the BMJ Group policy on declaration of interests and declare the following interests: The author has been provided funding by the Society of Actuaries and by the UK Institute and Faculty of Actuaries. In addition, a project led by the author, the Human Mortality Database, has received gifts from the Canadian Institute of Actuaries and from commercial insurance or re-insurance companies (SCOR, Hannover-Re, Reinsurance Of America, Munich-Re, and Milliman-France, Club Vita). The author is an unpaid volunteer member of the Society of Actuary Mortality and Longevity Steering Committee.
Comment on
-
Effect of the covid-19 pandemic in 2020 on life expectancy across populations in the USA and other high income countries: simulations of provisional mortality data.BMJ. 2021 Jun 23;373:n1343. doi: 10.1136/bmj.n1343. BMJ. 2021. PMID: 34162598 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical